Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J Innovation settles into a fast-paced global swirl of dealmaking
Fierce Biotech
Saturday, January 11, 2014 - 8:07am
tags:
JNJ Innovation, R&D
Completing a U-turn on RNA, Roche's resurgent pRED strikes deal with Santaris
Fierce Biotech
Saturday, January 11, 2014 - 8:06am
tags:
RNA, Roche, Santaris, pRED, R&D
Compounders start to sign up for FDA oversight
Fierce Pharma
Saturday, January 11, 2014 - 8:04am
tags:
FDA, compounding pharmacies, injectables
New Mandate Will Help Sell Veriteq's FDA-Approved Microchip
Seeking Alpha
Saturday, January 11, 2014 - 8:02am
tags:
FDA, Veriteq, devices, RFID chips
Shares of Chelsea Therapeutics Sink Ahead of FDA Review
Wall St Cheat Sheet
Saturday, January 11, 2014 - 8:01am
tags:
Chelsea Therapeutics, Northera, FDA
Biologic Makers Thwart Generics: Winning Stocks
Seeking Alpha
Saturday, January 11, 2014 - 8:00am
tags:
generics, biologics, Actavis, Mylan, Amgen, Novartis, Pfizer, Teva
Five Prime Therapeutics: A Small Cap With A Big Protein Therapeutic Platform
Seeking Alpha
Saturday, January 11, 2014 - 7:57am
tags:
Five Prime, protein therapeutics
Amgen spinoff Atara cranks its Series B up to $52M
Fierce Biotech
Friday, January 10, 2014 - 6:58pm
tags:
Amgen, Atara, Series B, oncology, kidney disease
KV gets a second shot at forcing the FDA to restrict compounders on Makena
Fierce Pharma
Friday, January 10, 2014 - 6:53pm
tags:
Makena, KV Pharmaceutical, FDA
Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients
Seeking Alpha
Friday, January 10, 2014 - 6:50pm
tags:
ARCA biopharma, atrial fibrillation, Gencaro
Arena Marches Up - Belviq Sales Show Traction
Seeking Alpha
Friday, January 10, 2014 - 6:49pm
tags:
Belviq, Arena Pharmaceuticals
What’s Next for Biotech?
Barron's
Friday, January 10, 2014 - 6:47pm
tags:
Celgene, Alexion, Incyte, Biomarin
Tonix Pharmaceuticals: Expect Pullback, Then Advance After TNX-102 Approval
Seeking Alpha
Friday, January 10, 2014 - 11:10am
tags:
Tonix Pharmaceuticals, TNX-102, fibromyalgia
Google X Staff Meet With FDA Pointing Toward New Device
Bloomberg
Friday, January 10, 2014 - 10:59am
tags:
Google X, FDA, devices
PET Imaging Market Poised To Grow With New Compounds
Forbes
Friday, January 10, 2014 - 10:57am
tags:
PET imaging, devices, Fluoropharma
Why Rexahn Pharmaceuticals (RNN) Is Up Today
TheStreet.com
Friday, January 10, 2014 - 10:56am
tags:
Rexahn, Archexin, Supinoxin, RX-3117
Inspire Medical's sleep apnea implant scores for majority in study
Fierce Medical Devices
Friday, January 10, 2014 - 10:36am
tags:
devices, Inspire Medical, sleep apnea, nerve stimulation jaw implant
Biotechs With Near-Term Catalysts That Should Rally
Seeking Alpha
Friday, January 10, 2014 - 10:34am
tags:
Ampio, Avanir, Chelsea Therapeutics, Endo Health Solutions, Optina, Northera, Synergy Pharmaceuticals, plecanatide, AVP-825, vintafolide
NuVasive Riding A New Wave Of Optimism
Seeking Alpha
Friday, January 10, 2014 - 10:20am
tags:
NuVasive, devices
Long-term efficacy of Chelsea drug may pose problems for FDA
Yahoo/Reuters
Friday, January 10, 2014 - 10:07am
tags:
Chelsea Therapeutics, FDA, Northera, Droxidopa, neurogenic orthostatic hypotension

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.